BJH - 2020, issue SPECIAL, november 2020
A. Dekker MD, T. Feys MBA, MSc
The first state of the art session of the 28th annual BSTH meeting focussed on venous thromboembolism and was moderated by Alain Gadisseur and Kristel Vandenbosch. Prof. P-YLeRoux (physician in the department of Nuclear Medicine at the Brest University Hospital, France, and senior scientist in the Thrombosis Study group of Western Brittany) opened this session with a talk on the diagnosis of acute pulmonary embolism. Following up on this presentation, prof. dr. S. Konstantinides (Professor for Clinical Trials and Medical director of the multidisciplinary centre for thrombosis and haemostasis (CTH) at the University of Mainz, Germany and professor of Cardiology at the Democritus University of Thrace, Greece), turned the attention to the clinical management of pulmonary embolism.
Read more
BJH - 2020, issue SPECIAL, november 2020
A. Dekker MD, T. Feys MBA, MSc
Jan Emmerechts and Christelle Orlando moderated the educational session of the 28th annual BSTH meeting focusing on the management of thromboprophylaxis and anticoagulation in critically ill patients during the COVID-19 pandemic. Prof. dr. M. Levi (University College London, London, United Kingdom) opened the session with a presentation on the latest evidence on the effects of a COVID-19 infection on thromboprophylaxis and coagulopathy. This presentation was followed up by Prof. Dr. T. Vanassche (University Hospitals Leuven and McMaster University, Hamilton) who gave a brief introduction on the new BSTH consensus guideline on anti-coaguation in patients with COVID-19. Finally, Dr D.J. Arachchillage (Hammersmith hospital in Imperial College Healthcare NHS Trust and Royal Brompton Hospital, London, United Kingdom) discussed the challenges of anticoagulation in critical care patients and in patients on mechanical cardiopulmonary support.
Read more
Top
